Informação sobre produto
- (6R,7R)-7-[[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(1H-1,2,3-triazol-5-ylthio)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- (6R,7R)-7-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-8-oxo-3-[(2H-1,2,3-triazol-4-ylsulfanyl)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- (6R,7R)-7-{[amino(4-hydroxyphenyl)acetyl]amino}-8-oxo-3-[(2H-1,2,3-triazol-4-ylsulfanyl)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- 1H-1,2,3-Triazole, 5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid deriv.
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(1H-1,2,3-triazol-5-ylthio)methyl]-, (6R,7R)-
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-amino(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(1H-1,2,3-triazol-4-ylthio)methyl]-, (6R,7R)-
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[amino(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(1H-1,2,3-triazol-4-ylthio)methyl]-, [6R-[6α,7β(R*)]]-
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid,7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(1H-1,2,3-triazol-5-ylthio)methyl]-,(6R,7R)-
- 7-[2-(4-Hydroxyphenyl)-2-Aminoacetamido]-3-(1,2,3-Triazole-4-Ylthio)Methyl-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid
- 7-[<span class="text-smallcaps">D</span>-α-Amino-α-(4-hydroxyphenyl)acetamido]-3-(1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid
- Ver mais sinónimos
- 7-{[amino(4-hydroxyphenyl)acetyl]amino}-8-oxo-3-[(2H-1,2,3-triazol-4-ylsulfanyl)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- Antibiotic BL-S 640
- Antibioticbl-640
- Antibioticbl-S640
- Bl-S 640
- Bls640
- Cefaperos
- Cephatriazine
- Cephatrizin
- Cephatrizine
- Cepticol
- Eta(R)))-
- Eta(R)))- L)Acetyl)Amino)-8-Oxo-3-((1H-1,2,3-Triazol-4-Ylthio)Methyl)-,(6R-(6-Alpha,7-B
- S 640P
- S640P
- Skf 60771
Cefatrizine is a clinical antimicrobial agent that inhibits the growth of gram-positive bacteria by binding to the 50S ribosomal subunit. It is used for the treatment of skin and soft tissue infections. Cefatrizine has been shown to be active against Streptococcus pyogenes, which are responsible for streptococcal pharyngitis and other infectious diseases. Cefatrizine also inhibits tetracycline resistance in both gram-positive and gram-negative bacteria, such as Enterococcus faecalis, which are responsible for urinary infections. This antibiotic also has a low toxicity in human serum and exhibits biological properties that are similar to nonsteroidal anti-inflammatory drugs (NSAIDs).
Propriedades químicas
Consulta técnica sobre: 3D-AC37979 Cefatrizine
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.